Peptide Injections AI
IGF-1 LR3 peptide therapy
Growth Hormone SecretionEmerging Evidence

IGF-1 LR3 Peptide Therapy

Benefits, Side Effects, Cost & Protocols

IGF-1 LR3 is a modified form of insulin-like growth factor 1 with an extended half-life and increased bioavailability. The LR3 modification makes it three times more potent than standard IGF-1, with effects on muscle growth, recovery, and cell proliferation.

ByChris Riley(CFA)&Alex Evans, PharmD, MBA(PharmD, MBA)|Updated

Clinically Reviewed

Reviewed by Alex Evans, PharmD, MBA · Updated May 2026

Evidence-Based

Sourced from FDA, PubMed & ClinicalTrials.gov · View sources

FDA Status
Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
Evidence
Emerging Evidence
Category
Growth Hormone Secretion

Who Is IGF-1 LR3 Best For?

Muscle growth research4 preclinical studiesCellular proliferation2 preclinical studiesRecoveryPrimarily animal or early-phase data

How IGF-1 LR3 Works

Long-acting IGF-1 variant that promotes cellular growth, muscle hypertrophy, and may have enhanced tissue-specific effects.

IGF-1 LR3 FAQ

What is IGF-1 LR3?

IGF-1 LR3 is a modified version of Insulin-like Growth Factor 1 with an extended half-life, researched for muscle growth and cellular proliferation.

How does IGF-1 LR3 work?

Long-acting IGF-1 variant that promotes cellular growth, muscle hypertrophy, and may have enhanced tissue-specific effects.

Is IGF-1 LR3 legal to buy?

IGF-1 LR3 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.

Where can I buy IGF-1 LR3?

IGF-1 LR3 is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.

What category does IGF-1 LR3 belong to?

IGF-1 LR3 is primarily classified as a growth hormone secretion peptide. Peptides that stimulate or support growth hormone release, including GHRH analogs, GHRPs, and direct GH compounds for muscle, recovery, and anti-aging research.

What are the research benefits of IGF-1 LR3?

IGF-1 LR3 has been studied for: Muscle growth research, Cellular proliferation, Recovery. Long-acting IGF variant; significant muscle research interest.

Key Studies

43 total on PubMed9 human trials

Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice

Engel MG, Narayan S, Cui MH et al

J Alzheimers DisAnimal

Intranasal LR3 IGF-1 remodeled amyloid plaques but did not preserve cognitive function in 5XFAD mice

IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep

White A, Stremming J, Wesolowski SR et al

Am J Physiol Endocrinol MetabAnimal

IGF-1 LR3 did not promote growth in late-gestation growth-restricted fetal sheep

Revolutionary decellularized Alstroemeria stem-based nerve conduit integrated with GelMA and controlled IGF-1 LR3 release for enhanced rat sciatic nerve regeneration

Yavuz E, Sağır MS, Ercan A et al

Int J Biol MacromolAnimal

Decellularized nerve conduit with GelMA and controlled IGF-1 LR3 release enhanced rat sciatic nerve regeneration

Attenuated glucose-stimulated insulin secretion during an acute IGF-1 LR3 infusion into fetal sheep does not persist in isolated islets

Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Peptide therapies have not been evaluated by the FDA for most listed indications.All prices shown are estimates based on publicly available data and may not reflect current pricing — providers and brands set their own prices and can change them at any time. Always verify pricing directly with the provider before purchasing. Consult a licensed healthcare provider before starting any peptide protocol.

Ready to explore IGF-1 LR3 with a provider?

Take our 2-minute quiz to get matched with a board-certified provider specializing in IGF-1 LR3.

Take the Quiz →